Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Transient Elastography as the First-Line Assessment of Liver Fibrosis and Its Correlation with Serum Markers

N. Uzlova, K. Mnozil Stridova, D. Merta, I. Rychlik, S. Frankova

. 2023 ; 59 (4) : . [pub] 20230412

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010447

Grantová podpora
COOP-ERATIO 34 - Internal Disciplines Charles University

Background and objectives: Recently, rapid progress has been made in the development of noninvasive methods for liver fibrosis assessment. The study aimed to assess the correlation between LSM and serum fibrosis markers to identify patients with advanced liver fibrosis in daily clinical practice. Methods: Between 2017 and 2019, 89 patients with chronic liver disease of various etiology, 58 males and 31 females, were enrolled in the study and underwent ultrasound examination, vibration-controlled transient elastography (VCTE), AST to Platelet Ratio Index (APRI score), Fibrosis-4 (FIB-4) score, and enhanced liver fibrosis (ELF) test. Results: The diagnoses were as follows: NAFLD (30.3%), HCV (24.3%), HBV (13.1%), ALD (10.1%), other (7.8%). Their median age was 49 (21-79), and their median BMI was 27.5 (18.4-39.5). The median liver stiffness measurement (LSM) was 6.7 kPa (2.9-54.2 kPa), the median of the ELF test was 9.0 (7.3-12.6), and the median APRI was 0.40 (0.13-3.13). Advanced fibrosis assessed by LSM was present in 18/89 (20.2%) patients. The LSM values correlated with the ELF test results (r2 = 0.31, p < 0.0001), with the APRI score (r2 = 0.23, p < 0.0001), the age of the patients (r2 = 0.14, p < 0.001), and with the FIB-4 values (r2 = 0.58, p < 0.0001). The ELF test values correlated with the APRI score (r2 = 0.14, p = 0.001), the age (r2 = 0.38, p < 0.0001), and the FIB-4 (r2 = 0.34, p < 0.0001). By determining the confidence intervals of the linear model, we proved that patients younger than 38.1 years have a 95% probability of absence of advanced liver fibrosis when assessed by VCTE. Conclusions: We identified APRI and FIB-4 as simple tools for screening liver disease in primary care in an unselected population of patients. The results also showed that individuals younger than 38.1 years had a negligible risk of advanced liver fibrosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010447
003      
CZ-PrNML
005      
20250402152924.0
007      
ta
008      
230718s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/medicina59040752 $2 doi
035    __
$a (PubMed)37109712
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Uzlova, Nikola $u Department of Internal Medicine, University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
245    10
$a Transient Elastography as the First-Line Assessment of Liver Fibrosis and Its Correlation with Serum Markers / $c N. Uzlova, K. Mnozil Stridova, D. Merta, I. Rychlik, S. Frankova
520    9_
$a Background and objectives: Recently, rapid progress has been made in the development of noninvasive methods for liver fibrosis assessment. The study aimed to assess the correlation between LSM and serum fibrosis markers to identify patients with advanced liver fibrosis in daily clinical practice. Methods: Between 2017 and 2019, 89 patients with chronic liver disease of various etiology, 58 males and 31 females, were enrolled in the study and underwent ultrasound examination, vibration-controlled transient elastography (VCTE), AST to Platelet Ratio Index (APRI score), Fibrosis-4 (FIB-4) score, and enhanced liver fibrosis (ELF) test. Results: The diagnoses were as follows: NAFLD (30.3%), HCV (24.3%), HBV (13.1%), ALD (10.1%), other (7.8%). Their median age was 49 (21-79), and their median BMI was 27.5 (18.4-39.5). The median liver stiffness measurement (LSM) was 6.7 kPa (2.9-54.2 kPa), the median of the ELF test was 9.0 (7.3-12.6), and the median APRI was 0.40 (0.13-3.13). Advanced fibrosis assessed by LSM was present in 18/89 (20.2%) patients. The LSM values correlated with the ELF test results (r2 = 0.31, p < 0.0001), with the APRI score (r2 = 0.23, p < 0.0001), the age of the patients (r2 = 0.14, p < 0.001), and with the FIB-4 values (r2 = 0.58, p < 0.0001). The ELF test values correlated with the APRI score (r2 = 0.14, p = 0.001), the age (r2 = 0.38, p < 0.0001), and the FIB-4 (r2 = 0.34, p < 0.0001). By determining the confidence intervals of the linear model, we proved that patients younger than 38.1 years have a 95% probability of absence of advanced liver fibrosis when assessed by VCTE. Conclusions: We identified APRI and FIB-4 as simple tools for screening liver disease in primary care in an unselected population of patients. The results also showed that individuals younger than 38.1 years had a negligible risk of advanced liver fibrosis.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    12
$a elastografie $x škodlivé účinky $x metody $7 D054459
650    _2
$a biopsie $x metody $7 D001706
650    _2
$a jaterní cirhóza $x diagnostické zobrazování $x etiologie $7 D008103
650    _2
$a játra $x patologie $7 D008099
650    _2
$a biologické markery $7 D015415
650    _2
$a fibróza $7 D005355
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mnozil Stridova, Katerina $u Department of Internal Medicine, University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
700    1_
$a Merta, Dusan $u Anaesthesiology and Resuscitation Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic $u First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic
700    1_
$a Rychlik, Ivan $u Department of Internal Medicine, University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000242455949 $7 jx20050531034
700    1_
$a Fraňková, Soňa $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic $1 https://orcid.org/0000000214625920 $7 xx0329475
773    0_
$w MED00180386 $t Medicina $x 1648-9144 $g Roč. 59, č. 4 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37109712 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20250402152921 $b ABA008
999    __
$a ok $b bmc $g 1963081 $s 1196712
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 59 $c 4 $e 20230412 $i 1648-9144 $m Medicina $n Medicina (Kaunas) $x MED00180386
GRA    __
$a COOP-ERATIO 34 - Internal Disciplines $p Charles University
LZP    __
$a Pubmed-20230718
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace